Tinnitus retraining therapy (TRT) is a useful treatment for tinnitus. The aim of this study was to evaluate the resultsobtained after 18 months of TRT as well as 18 months after completion of therapy, i.e. 36 months after initiation of TRT. Forty-five subjects suffering from an idiopathic tinnitus with or without hyperacusis for at least 6 months were recruited. There were significant improvements during therapy (p < 0.001) and the mean Tinnitus Handicap Inventory (THI) was lowered by more than 20 points. These improvements persisted 18 months after treatment completion. Furthermore, the percentage of patients reporting the disappearance of their difficulties in various activities (relaxation, concentration, sleep, social relations and work) increased continuously after treatment completion. TRT improved self-perceived disability induced by chronic tinnitus for a long time after the end of therapy.

1.
Baracca GN, Forti S, Crocetti A, Fagnani E, Scotti A, Bo LD, Ambrosetti U: Results of TRT after eighteen months: our experience. Int J Audiol 2007;46:217–222.
2.
Berry JA, Gold SL, Frederick EA, Gray WC, Staecker H: Patient-based outcomes in patients with primary tinnitus undergoing tinnitus retraining therapy. Arch Otolaryngol Head Neck Surg 2002;128:1153–1157.
3.
Hatanaka A, Ariizumi Y, Kitamura K: Pros and cons of tinnitus retraining therapy. Acta Otolaryngol 2008;128:365–368.
4.
Henry JA, Jastreboff MM, Jastreboff PJ, Schechter MA, Fausti SA: Assessment of patients for treatment with tinnitus retraining therapy. J Am Acad Audiol 2002;13:523–544.
5.
Herraiz C, Hernandez FJ, Toledano A, Aparicio JM: Tinnitus retraining therapy: prognosis factors. Am J Otolaryngol 2007;28:225–229.
6.
Jastreboff PJ: Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 1990;8:221–254.
7.
Jastreboff PJ: The neurophysiolgical model of tinnitus and hyperacusis; in Hazell J (ed): Sixth International Tinnitus Seminar, London, 1999, pp 32–38.
8.
Jastreboff PJ: Tinnitus retraining therapy. Prog Brain Res 2007;166:415–423.
9.
Jastreboff PJ, Hazell JWP: Tinnitus retraining therapy: implementing the neurophysiological model. Cambridge, Cambridge University Press, 2004.
10.
Jastreboff PJ, Jastreboff MM: Tinnitus Retraining Therapy (TRT) as a method for treatment of tinnitus and hyperacusis patients. J Am Acad Audiol 2000;11:162–177.
11.
Jastreboff PJ, Jastreboff MM: Tinnitus retraining therapy: a different view on tinnitus. ORL J Otorhinolaryngol Relat Spec 2006;68:23–29; discussion 29–30.
12.
Lux-Wellenhof G, Hellweg FC: Long-term follow-up study of TRT in Frankfurt; in Patuzzi RB (ed): Proceedings of the Seventh International Tinnitus Seminar, Perth, March 2002.
13.
Margolis RH, Saly GL: Toward a standard description of hearing loss. Int J Audiol 2007;46:746–758.
14.
Mazurek B, Fischer F, Haupt H, Georgiewa P, Reisshauer A, Klapp BF: A modified version of tinnitus retraining therapy: observing long-term outcome and predictors. Audiol Neurootol 2006;11:276–286.
15.
McKinney DJ, Hazell JWP, Graham R: An evaluation of the TRT method; in Hazell J (ed): The Sixth International Tinnitus Seminar; The Tinnitus and Hyperacusis Centre, London, 1999, pp 99–105.
16.
Newman CW, Jacobson GP, Spitzer JB: Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996;122:143–148.
17.
Wang H, Jiang S, Yang W, Han D: Tinnitus retraining therapy: a clinical control study of 117 patients (in Chinese). Zhonghua Yi Xue Za Zhi 2002;82:1464–1467.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.